Related references
Note: Only part of the references are listed.From Cytokines to Toll-Like Receptors and Beyond - Current Knowledge and Future Research Needs in Irritable Bowel Syndrome
Oscar Rodríguez-Fandiño et al.
Journal of Neurogastroenterology and Motility (2011)
An Orally Applicable Shiga Toxin Neutralizer Functions in the Intestine To Inhibit the Intracellular Transport of the Toxin
Miho Watanabe-Takahashi et al.
INFECTION AND IMMUNITY (2010)
Distinct Physiologic and Inflammatory Responses Elicited in Baboons after Challenge with Shiga Toxin Type 1 or 2 from Enterohemorrhagic Escherichia coli
D. J. Stearns-Kurosawa et al.
INFECTION AND IMMUNITY (2010)
Macropinocytosis in Shiga toxin 1 uptake by human intestinal epithelial cells and transcellular transcytosis
Irina Malyukova et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2009)
Gnotobiotic Piglet Infection Model for Evaluating the Safe Use of Antibiotics against Escherichia coli O157:H7 Infection
Quanshun Zhang et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Early erythropoietin reduced the need for red blood cell transfusion in childhood hemolytic uremic syndrome-a randomized prospective pilot trial
Lars Pape et al.
PEDIATRIC NEPHROLOGY (2009)
Shiga toxin 1 induces apoptosis through the endoplasmic reticulum stress response in human monocytic cells
Sang-Yun Lee et al.
CELLULAR MICROBIOLOGY (2008)
Intracellular neutralization of Shiga toxin 2 by an a subunit-specific human monoclonal antibody
Greice Krautz-Peterson et al.
INFECTION AND IMMUNITY (2008)
Duration of oliguria and anuria as predictors of chronic renal-related sequelae in post-diarrheal hemolytic uremic syndrome
Robert S. Oakes et al.
PEDIATRIC NEPHROLOGY (2008)
Induction of IRAK-M is associated with lipopolysaccharide tolerance in a human endotoxemia model
Cornelis van 't Veer et al.
JOURNAL OF IMMUNOLOGY (2007)
Incidence and Tracking of Escherichia coli O157:H7 in a Major Produce Production Region in California
Michael Cooley et al.
PLOS ONE (2007)
A multivalent peptide library approach identifies a novel Shiga toxin inhibitor that induces aberrant cellular transport of the toxin
Kiyotaka Nishikawa et al.
FASEB JOURNAL (2006)
A murine model of HUS: Shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease
Tiffany R. Keepers et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Sepsis and pathophysiology of anthrax in a nonhuman primate model
Deborah J. Stearns-Kurosawa et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Predictors of fatality in postdiarrheal hemolytic uremic syndrome
RS Oakes et al.
PEDIATRICS (2006)
Targeted disruption of Gb3/CD77 synthase gene resulted in the complete deletion of globo-series glycosphingolipids and loss of sensitivity to vVerotoxins
T Okuda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Systematic review: are antibiotics detrimental or beneficial for the treatment of patients with Escherichia coli O157 : H7 infection?
G. Z. Panos et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Shiga toxin enhances functional tissue factor on human glomerular endothelial cells: implications for the pathophysiology of hemolytic uremic syndrome
E Nestoridi et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections
M Watanabe et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
A new family of potent AB5 cytotoxins produced by Shiga toxigenic Escherichia coli
AW Paton et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Shiga toxin 1 triggers a ribotoxic stress response leading to p38 and JNK activation and induction of apoptosis in intestinal epithelial cells
WE Smith et al.
INFECTION AND IMMUNITY (2003)
Prophylactic heparinization is ineffective in a primate model of hemolytic uremic syndrome
RL Siegler et al.
PEDIATRIC NEPHROLOGY (2002)
Shiga toxin-2 triggers endothelial leukocyte adhesion and transmigration via NF-κB dependent up-regulation of IL-8 and MCP-1
C Zoja et al.
KIDNEY INTERNATIONAL (2002)
Escherichia coli O157:H7 infections:: Discordance between filterable fecal Shiga toxin and disease outcome
NA Cornick et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Expression of vascular endothelial growth factor receptors 1, 2, and 3 in quiescent endothelia
AN Witmer et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2002)
Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome
WL Chandler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Platelet activation by Shiga toxin and circulatory factors as a pathogenetic mechanism in the hemolytic uremic syndrome
D Karpman et al.
BLOOD (2001)
The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections
CS Wong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Escherichia coli O157:H7 strains that express Shiga toxin (Stx) 2 alone are more neurotropic for gnotobiotic piglets than are isotypes producing only Stx1 or both Stx1 and Stx2
A Donohue-Rolfe et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Peritonitis in the baboon: A primate model which simulates human sepsis
GT Kinasewitz et al.
SHOCK (2000)
Toxin gene expression by shiga toxin-producing Escherichia coli: the role of antibiotics and the bacterial SOS response
PT Kimmitt et al.
EMERGING INFECTIOUS DISEASES (2000)
Share Paper
